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ABSTRACT: Familial hypertelorism, characterized by widely
spaced eyes, classically shows autosomal dominant inheri-
tance (Teebi type), but some pedigrees are compatible with
X-linkage. No mechanism has been described previously,
but clinical similarity has been noted to craniofrontonasal
syndrome (CFNS), which is caused by mutations in the
X-linked EFNB1 gene. Here we report a family in which
females in three generations presented with hypertelorism,
but lacked either craniosynostosis or a grooved nasal tip,
excluding CFNS. DNA sequencing of EFNB1 was normal,
but further analysis revealed a duplication of 937kb
including EFNB1 and two flanking genes: PJA1 and
STARD8. We found that the X chromosome bearing the
duplication produces  1.6-fold more EFNB1 transcript
than the normal X chromosome and propose that, in the
context of X-inactivation, this difference in expression level
of EFNB1 results in abnormal cell sorting leading to
hypertelorism. To support this hypothesis, we provide
evidence from a mouse model carrying a targeted human
EFNB1 cDNA, that abnormal cell sorting occurs in the
cranial region. Hence, we propose that X-linked cases
resembling Teebi hypertelorism may have a similar
mechanism to CFNS, and that cellular mosaicism for
different levels of ephrin-B1 (as well as simple presence/
absence) leads to craniofacial abnormalities.
Hum Mutat 32:930–938, 2011. & 2011 Wiley-Liss, Inc.
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Introduction
Ocular hypertelorism (hereafter referred to as hypertelorism),
meaning abnormally widely spaced eyes, may manifest in isolation
(MIM] 145400), as the primary abnormality in brachycephalo-
frontonasal dysplasia (Teebi hypertelorism) (MIM] 145420), or in
association with several syndromes. Hypertelorism is prominent
in craniofrontonasal syndrome (CFNS; MIM] 304110) and is the
only feature of this X-linked developmental disorder that is
commonly shared by heterozygous females and hemizygous males
[Grutzner and Gorlin, 1988]. Females with CFNS are paradoxi-
cally more severely affected than males, additionally exhibiting
frontonasal dysplasia with a central nasal groove, unilateral or
bilateral coronal craniosynostosis, and extracranial features,
whereas males normally have no other malformations. The
classical CFNS female phenotype is caused by heterozygous loss-
of-function mutations in EFNB1 (MIM] 300035), which encodes
the transmembrane signaling molecule ephrin-B1 [Twigg et al.,
2004; Wieland et al., 2004]. Over 80 distinct mutations of EFNB1
have been reported in CFNS; these molecular lesions show a wide
diversity ranging from missense substitutions to complete gene
deletions, but no genotype–phenotype correlation is evident. All
CFNS mutations are believed to cause partial or complete loss of
ephrin-B1 function [Twigg and Wilkie, 2008].
Ephrins and their Eph receptors have been shown to play
important roles in development and homeostasis through control
of several cellular processes mediated via bidirectional cell contact-
dependent signalling [Arvanitis and Davy, 2008; Pasquale, 2008].
Frequently, expression of Eph receptors and ephrins is reciprocal
and, through repulsive interactions at interfaces, organizes
positioning and/or movement of cells including the restriction of
migrating neural crest cells (NCC) to specific embryonic territories
[Wilkinson, 2001]. Murine Efnb1 is expressed in neural crest but
not in the cephalic mesoderm; hence, the coronal suture, which
develops at the interface between these tissues, lies at the boundary
of Efnb1 expression [Twigg et al., 2004]. The occurrence of
craniosynostosis in CFNS suggests that ephrin-B1 may play a role
in establishing and/or maintaining the separation of these tissues.
Insight into the paradoxical inheritance pattern of CFNS was
provided by analysis of the knock-out (KO) Efnb1 mouse, in which
heterozygous females also have a more severe phenotype than either
hemizygous males or homozygous females [Compagni et al., 2003].
This has led to a model of pathogenesis whereby the process of
random X-inactivation in the heterozygous female leads to patchy
ephrin-B1 expression, which is accentuated by the homophilic
sorting of cells that do, or do not, express ephrin-B1. The result is
that ectopic tissue boundaries are formed, a process that has been
termed ‘‘cellular interference,’’ and cannot occur in hemizygous
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males suggest that ephrin-B1 function is redundant in most tissues
where it is expressed. Further indications that ephrins play a wider
role in the developing skull vault come from the identification of
heterozygous mutations in EFNA4, encoding ephrin-A4, in patients
with nonsyndromic unicoronal craniosynostosis [Merrill et al.,
2006], and from partial fusion of the coronal sutures in mice
homozygous for an EphA4 null allele [Ting et al., 2009].
Here we report a female patient with severe hypertelorism and
mild nail ridging but without craniosynostosis or other features of
CFNS. Because of the phenotypic overlap with CFNS, the patient’s
DNA was screened for mutations and for copy number variation
in EFNB1 by sequence analysis and multiplex ligation-dependent
probe amplification (MLPA), respectively. Unexpectedly, MLPA
revealed a duplication of all five exons of EFNB1. We present the
further molecular genetic investigation of this family and show
that the duplicated EFNB1 allele generates approximately 1.6-fold
as much transcript as the normal allele. We also provide evidence
that allelic imbalance in a mouse model (Efnb1
Lox) targeted to
contain a human EFNB1 cDNA in place of the endogenous Efnb1
gene results in aberrant cell mixing of the cranial primordia
during development. Taken together, these data suggest that
cellular mosaicism for different levels of ephrin-B1 (as well as
simple presence/absence) leads to craniofacial abnormalities.
Methods
Clinical Ascertainment and Initial Diagnostic Studies
The family was initially referred to the local clinical genetics service
for assessment. Ethical approval for research into craniofacial
malformations was provided by the Oxfordshire Research Ethics
Committee B (C02.143), and informed consent was obtained from
all participants by clinical staff, in accordance with local guidelines.
Genetic analyses were performed on DNA and RNA extracted from
peripheral blood. The human genome hg18 sequence release (March
2006) was used for all analyses presented in this article.
The duplication was originally detected by MLPA analysis
conducted according to the manufacturer’s instructions using the
P080 kit (MRC Holland). The extent of the duplication was
determined by array comparative genomic hybridization (array
CGH) using a 244 K array (Agilent Technologies, Englewood, CO)
according to the manufacturer’s instructions. The hybridized
arrays were washed and scanned using an Agilent Microarray
Scanner, the image data were extracted using Agilent Feature
Extraction software version 8.5, and analyzed using Agilent CGH
Analytics software version 3.4 (z-score method setting). Fluores-
cence in situ hybridization (FISH) characterization of the
duplication was conducted using a bacterial artificial chromosome
(BAC) clone RP11-30P7 (Invitrogen, Carlsbad, CA) that spans the
EFNB1 gene region. Probe generated from BAC clones was labeled
with digoxygenin and detected with fluorescein.
Isolation of Duplication Breakpoint
Single copy probes spanning a 36-kb region to include the
centromeric limit of the duplicated segment were synthesized and
hybridized to Southern blots of patient and control DNA. Initially,
a 6-kb HindIII breakpoint fragment was identified that indicated
the breakpoint lay in a 1,933-bp region. Further localization on
Southern blots by looking for additional breakpoint fragments
revealed the order and relative positions of restriction enzyme sites
around the telomeric limit of the duplicated segment. A restriction
map of a 26-kb region containing this telomeric limit was
generated from published sequence and compared to the map
determined from Southern analysis. This allowed the breakpoint
to be identified as lying within a  1-kb region. A primer pair was
designed that amplified a unique 1,095-bp product from the
patient’s DNA: 50-TGCATCGCTCATGCTGGGAGCTGTAGAC-30
and 50-GTGCTGTATTCAGGAGACCCATATCACGTGCA-30. After
DNA sequencing to determine the site of the breakpoint, a further
primer pair (50-GGTAATGTGTCATTTCCCTCTGTCTCCTTT-
CAG-30 and 50-ACAGAAACTGAACGACCTGCTCTTGAATGAC-
TA-30) was designed to confirm the breakpoint in other family
members by amplifying a 250-bp fragment in a multiplex reaction
with a normal control primer pair designed to amplify a fragment
of GLI2 on chromosome 2 (50-TGTCGGGGACATGAGCTC-
CATGCTCAC-30 and 50-CCGGAGCAGAGTATCCAGTATAGCA-
TTCAGA-30).
Relative EFNB1 Expression and Correction for Skewed
X-Inactivation
Total RNA was isolated from peripheral blood using the
PAXgene Blood RNA Kit (Qiagen, UK), treated with DNAseI
(Roche, Indianapolis, IN), and cDNAwas generated using random
hexamer primers (RevertAid, Fermentas, Hanover, MD). cDNA
was amplified using primers shown in Figure 4 and the SNPs
rs16990748 and rs688969, which are in complete linkage
disequlibrium and lie 2bp apart in the 30 untranslated region of
EFNB1, were used to quantify the relative expression of the EFNB1
alleles in the heterozygous individual I-2. Correction for
differential X-inactivation was achieved using the SNP
rs1620574 in XIST, which was also heterozygous in I-2.
Relative amounts of each allele were quantified by pyrosequen-
cing. Single-stranded PCR products (see Fig. 4 for details) were
obtained by using a single biotinylated primer, immobilization on
streptavidin beads, and denaturation with NaOH. Products were
annealed to the sequencing primer by heating to 801C for 2min.
Pyrosequencing [Langaee and Ronaghi, 2005] was performed on
three independent amplification products from control and patient
samples on a PSQ-HS96A system (Qiagen), with use of primers
and dispensation orders designed to quantify the normal and
duplicated allele of EFNB1 and XIST alleles. Each pyrogram was
required to pass three criteria to ensure only high-quality data were
analyzed: absence of duplication-specific peaks in control samples,
no decrease in peak height as dispensation progressed, and no
unexpected peaks from blank dispensations. Peak heights were
recorded using PSQ96 SQA software and the values exported to a
MS Excel data sheet. For each pair of peaks selected for
quantification, the normal/duplicated peak ratio was obtained.
Quadratic interpolation was applied for deviations from expected
0, 50, 67, and 100% for the control samples.
The correct phase between the duplicated EFNB1 allele and
XIST SNP in subject I-2 was confirmed by amplifying 10
microsatellites in the four siblings of I-2 and in the three affected
family members, using primers labelled with the fluorophore
6-FAM (primer pairs are shown in Supp. Table S1). Fragments
were analysed by capillary electrophoresis on an ABI 3130
containing POP-7 polymer. Peaks were visualized using Gene
Mapper v3.7 (Applied Biosystems, Bedford, MA).
Analysis of Efnb1
Lox Mice
Mice carrying a conditional Efnb1
Lox allele on a C57Bl/6J
background [Compagni et al., 2003] were a gift from R. Adams
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analyzed using mice carrying an X-linked green fluorescent
protein (GFP) transgene (D4/XEGFP) [Hadjantonakis et al.,
2001]. EphB2 expression was determined by b-galactosidase
staining in mice carrying an allele targeted to generate an
EphB2–LacZ fusion protein [Henkemeyer et al., 1996].
For b-galactosidase staining, embryos were fixed in 1%
formaldehyde, 0.2% glutaraldehyde, 5mM EGTA, 2mM MgCl2,
and 0.02% NP-40, and incubated in staining solution containing
5mM potassium ferricyanide, 5mM potassium ferrocyanide,
2mM MgCl2, 0.01% sodium deoxycholate, 0.2% NP-40, and
1mg/mL X-gal.
To visualize GFP on histological sections, embryos were fixed in
4% paraformaldehyde at 41C, washed three times in phosphate-
buffered saline, embedded in OCT-compound (R.A. Lamb), and
cut on a cryostat (Leica, Deerfiled, IL) at 15mM. Specimens were
viewed and photographed using a Leica MZFLIII microscope and
DFC300F camera. Images were viewed and stored using Openlab
software (Improvision).
Specimens for micro-CT were scanned using a General Electric
Locus SP micro-CT scanner (GE Healthcare, Piscataway, NJ). The
specimens were immobilized using cotton gauze and scanned to
produce 14–28mm voxel size volumes. The specimens were
characterized further by making three-dimensional isosurfaces,
generated and measured using Microview software (GE Healthcare).
Expression of the EFNB1 cDNA was compared with endogen-
ous Efnb1 in Efnb1
Lox and wild-type (wt) male mice, respectively.
Total RNA was isolated from adult brain and E15.5 embryonic
heads using RNA-Bee (AMS Biotechnology, Abingdon, UK),
treated with DNAseI (Roche), and cDNA was generated using
random hexamer primers (RevertAid, Fermentas). Quantification
of expression by real-time PCR was conducted using a primer pair
to amplify a cDNA fragment spanning exon 1 and exon 2 of the
endogenous Efnb1 gene that is preserved in the Efnb1
Lox targeted
allele (50-CAGGCGAGGCGAGCTTTGCTGAG-30 and 50-CAGC-
TTGTCTCCAATCTTCGGGTAGATCAC-30). Expression was
normalized using two control genes, Gapdh (50-CATGGCC
TTCCGTGTTCCTA-30 and 50-CCTGCTTCACCACCTTCTT-
GAT-30) and the ribosomal protein encoding gene Rplp0
(50-CACTGAGATTCGGGATATGCTGTTGGCCAAT-30 and 50-CT-
TCTCGGGTCCTAGACCAGTGTTCTGA-30). Amplification reac-
tions were monitored using SYBR Green I Master (Roche) in a
Light Cycler 480II (Roche). Between six and eight independent
reactions were obtained for each tissue/primer pair combination.
Results are expressed as the mean7standard error of the mean
(SEM) of the cycle at which each reaction reached a predeter-
mined threshold (Ct) relative to the wt level.
Results
Case Report
The proband III-3 (pedigree shown in Fig. 1A) was referred for
a clinical genetics opinion at the age of 7.9 years because of
dysmorphic features, short stature, and mild developmental delay.
On examination she was noted to have marked hypertelorism, a
widow’s peak, frontal bossing, thick eyebrows, a short nose, and
arched upper lip (Fig. 1B and C). There was mild nail ridging. She
attended a normal school but required additional support in class.
She had been born at 38 weeks’ gestation with a weight of 3.55kg
(11.3 SD), walked at 18 months, and had no words until 2 years.
Formal measurements at the age of 9.0 years documented a height
of 111cm ( 3.8 SD), head circumference 55cm (12.4 SD) and
inner canthal distance 4.4cm (16 SD). An umbilical hernia
required surgical repair at the age of 11 years. In the family
Figure 1. Pedigree and phenotype of individuals heterozygous for EFNB1 duplication. A: Pedigree showing the immediate family of the
proband (arrow). Filled symbols represent individuals shown to carry the duplication. Under each symbol, haplotypes of loci assayed in EFNB1
and XIST are shown together with duplication status of each X chromosome (see key). Note that the X chromosome bearing the duplication
(marked in red in the duplicated individuals and in the nonduplicated sisters of I-2) is identified by a C allele at the EFNB1 and XIST SNPs. na
indicates that no DNA was available for analysis. B,C: Facial appearance of the proband, aged 10 years. D: Proband’s mother (II-2) aged 41 years
and E, grandmother (I-2) aged 63 years.
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(inner canthal distance 4.2cm, 14.7 SD), who exhibited mild nail
ridging, and maternal grandmother I-2 (Fig. 1E) (inner canthal
distance 4.0cm, 13.6 SD); both were generally healthy and of
normal stature (173cm [11.6 SD] and 165cm [10.2 SD],
respectively) and intelligence and neither had a history of
recurrent miscarriages. No other family members had hypertelor-
ism. Three-dimensional computed skull tomography of subject
III-3 demonstrated hypertelorism with vertical displacement of
the right orbit. There was no evidence of craniosynostosis and the
appearance of the brain was normal. The remainder of the skeletal
survey was normal.
Characterization of a 937-kb Duplication Including EFNB1
The segregation of hypertelorism in three generations suggested
a possible diagnosis of Teebi hypertelorism syndrome, but in view
of the clinical overlap with CFNS, mutation testing of EFNB1 was
arranged. Screening for mutations in the coding region was
normal, but MLPA analysis revealed a duplication of all five exons
of EFNB1 (Fig. 2A). Subsequently, array CGH using a 244 K
oligonucleotide array (see Methods) confirmed the presence of a
duplication within the band Xq13.1, including the EFNB1 gene,
approximately 888–950kb in size (Fig. 2B). FISH analysis showed
that the duplication appeared to have occurred in tandem on
Xq13.1 (Fig. 2C).
The sequence around the duplication limits, delineated by array
CGH (Fig. 2B), was analyzed in order to design single copy probes
for Southern blotting. Because the telomeric limit of the
duplication contained greater than 95% repetitive sequence, we
designed probes to span the centromeric limit. Following two
rounds of restriction site mapping by Southern blot analysis, the
duplication limits were sufficiently localized to enable design of a
PCR primer pair to amplify across the duplication breakpoint (see
Methods). DNA sequencing of this product identified the
molecular structure of the breakpoint (Fig. 3). The sequences
show no significant similarity except for a shared 6-bp TTCTTA
motif. The centromeric duplication limit lies between 67,664,244
and 67,664,249bp and the telomeric duplication limit between
68,600,907 and 68,600,912bp, revealing the size of the duplicated
region as 936,663bp. Analysis of the normal sequences at the two
breakpoints shows the proximal breakpoint to be in an L1 LINE
(L1P2) repetitive element, whereas the distal breakpoint resides in
the 30 terminal end of an L1MDa repetitive element.
We designed a duplex PCR assay to simultaneously amplify the
duplication breakpoint and a control sequence in GLI2 (see
Methods) to determine whether other family members carried the
duplication. We found the identical duplication in the proband’s
mother II-2 and maternal grandmother I-2 (Fig. 2D). The
duplication was not present in the proband’s half sisters III-1
and III-2, her maternal grandfather I-1 (Fig. 2D), or in any of the
four siblings of I-2 (not shown). These results were confirmed by
MLPA. The MLPA analysis of the sample from the blood of I-2
indicated a 1.5-fold increase in dosage of all five exons of EFNB1,
suggesting a complete rather than mosaic duplication in this
individual (not shown).
The duplication includes three complete genes (STARD8,
EFNB1, and PJA1), while the final exon of YIPF6, a 7-exon gene,
Figure 2. Molecular and cytogenetic characterization of X-chromosome duplication including EFNB1. A: MLPA analysis of the proband III-3
(lower panel) compared with a normal female control (upper panel). The estimated dose of EFNB1 exons 1–5 in the proband is  1.5 compared
with 31 autosomal amplicons. B: Plot showing extent of duplication determined by array CGH. Probes apparently duplicated in the proband are
shown in green, indicating a duplication size of  900kb. C: FISH with BAC clone RP11-30P7. This clone spans the EFNB1 gene and hybridizes to
the X chromosomes only, with one chromosome showing a brighter signal, consistent with a tandem duplication of the EFNB1 region. D: Duplex
PCR assay for duplication junction (lower fragment) and GLI2 amplification control (upper fragment). Pedigree symbols are aligned above
corresponding lanes; H2O, water control. na indicates that no DNA was available for analysis.
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duplication with the hypertelorism phenotype in the family
(Fig. 1A). Given the similarity of the phenotype in this family to
CFNS, we speculate that the duplication of the EFNB1 gene is
likely to cause the hypertelorism. We therefore sought to
determine whether the X-chromosome that carries the duplication
produces a larger amount of EFNB1 mRNA.
Quantification of EFNB1 Expression Level and Correction
for Skewing of X-Inactivation
To develop an assay for imbalance in EFNB1 mRNA expression,
we searched for an informative polymorphism by sequencing the
entirety of EFNB1, including the 50 and 30 untranslated regions
(UTRs) in the three affected family members. II-2 and III-3 were
uninformative, but I-2 was heterozygous for two closely adjacent
A/C polymorphisms (rs16990748 and rs688969). This enabled us
to distinguish in subject I-2 the X chromosomes carrying the
normal (AAAA genotype) and duplicated (ACAC genotype) copies
of EFNB1 (Fig. 1A). A Pyrosequencing assay was designed (see
Methods and Fig. 4A) to quantify the relative expression of the two
alleles in cDNA generated from peripheral blood. From this we
estimated that 74.0% (SEM 2.3%; n53) of the EFNB1 expressed
in these cells originated from the duplicated allele (Fig. 4A).
To correct for any skewing of X-inactivation, we screened the
DNA of subject I-2 for linked informative polymorphisms. The
well-characterized trinucleotide repeat within the AR locus was
not informative, but subject I-2 was heterozygous for a C/T
polymorphism (rs1620574) within the XIST locus at 72,960,792bp,
 4.36Mb distal of the telomeric limit of the duplication (Fig. 1A).
XIST is transcribed exclusively from the inactive X chromosome
[Brown et al., 1991] and we adapted a published method [Rupert
et al., 1995] to quantify the proportion of each allele in the cDNA
samples used to quantify EFNB1 expression (see Methods and Fig.
4B). Analysis of available family members showed that the C allele
was present on the duplicated X chromosome in subjects II-2 and
III-3 (Fig. 1A). From the Pyrosequencing assay we estimated that
the C allele accounted for 35.8% (SEM 0.3%; n53) of the total XIST
transcript level, indicating that the X chromosome containing the
duplication was active in 64.2% of cells. Combining these data
using the formula (74.0/64.2)/(26.0/35.8) indicates a 1.6-fold
increase of EFNB1 transcription from the duplicated allele.
The genetic distance between EFNB1 and XIST indicates a
 3.1% chance that a recombination could have occurred between
subjects I-2 and II-2, which would reverse the phase of the SNP
alleles in I-2. To exclude this, we genotyped 10 informative
microsatellite markers in each affected family member and four
siblings of I-2 (Fig. 1A). Markers were selected to be either
centromeric of EFNB1 or telomeric of XIST, marker locations are
shown in Supp. Table S1. Two sisters of I-2 (I-3 and I-4) had
identical genotypes to I-2 at all 10 locations, yet did not carry the
EFNB1 duplication; the three sisters shared a haplotype that was
transmitted to II-2 and III-3 (data not shown). This makes it very
unlikely that a recombination between EFNB1 and XIST has
occurred in any of these family members, and also demonstrates
that the duplication arose de novo in I-2.
Abnormal Tissue Mixing in Efnb1
Lox/1 Mice
To investigate further whether imbalance in expression of
ephrin-B1 in different cells (as well as simple presence or absence)
can lead to phenotypic abnormalities, we obtained mice carrying a
loxP-flanked human EFNB1 cDNA cassette knocked into the
endogenous Efnb1 gene on the X-chromosome (here referred to as
the conditional Efnb1
Lox allele) [Compagni et al., 2003]. Mice
heterozygous, homozygous or hemizygous for this conditional
Efnb1
Lox allele show reduced viability,  10% dying within 24hr
after birth due to cleft palate [Compagni et al., 2003].
The amount of protein produced from the conditional allele
was previously reported to be reduced compared with the wt
allele, based on Western blotting [Compagni et al., 2003].
However, as the conditional allele contains a human cDNA and
Figure 3. DNA sequence characterization of X chromosome duplication. The upper panel shows positions and directions of transcription of
genes in the region and the size and extent of the duplicated segment (rectangular box). Below, the DNA sequence chromatogram spanning the
breakpoint and alignment of this sequence compared to the normal sequences at the telomeric and centromeric limits of the duplication. The
arrowheads indicate the range of possible positions of the breakpoint within the six-nucleotide identity (shaded) shared by both normal sequences.
[Color figures can be viewed in the online issue, which is available at www.wiley.com/humanmutation.]
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equivalent affinity, we undertook to quantify transcript levels. To
circumvent the differences between the wt and conditional alleles,
a primer pair was designed to amplify a region including exon 1
and exon 2 from the endogenous Efnb1 gene that is preserved in
the conditional allele (see Methods). Expression levels in each
tissue were normalized using the transcripts Gapdh and Rplp0,
fragments of which were amplified using previously described
primers [Tsujita et al., 2006; Xu et al., 2010]. In adult brain (Supp.
Fig. S1), expression of the conditional allele was between 1.69- and
2.75-fold higher than the wt locus. By contrast, in the developing
heads of embryonic day (E)15.5 embryos we found no clear
difference in expression of the alleles; the conditional allele
appeared either increased 1.16-fold or decreased to 0.76-fold
according to whether the Rplp0 or Gapdh transcript was used for
normalization, respectively. Taken together, these data indicate
that expression of the conditional allele varies relative to the wt
allele in a time- and tissue-specific manner, and demonstrates
significant upregulation in adult brain.
Given that these subtle alterations in expression of the
conditional allele partly mimic the effect of the human EFNB1
duplication, we investigated the craniofacial phenotypes of
Efnb1
Lox/1 mice in greater detail. We found that  10% of viable
Efnb1
Lox/1 heterozygous females exhibit obvious twisting of the
skull. Micro-CT scanning shows that this appears to originate in
the frontal bones around the level of the anterior frontal suture
(Fig. 5A). The interorbital distance of Efnb1
Lox/1 mutants was
significantly (1.15-fold) larger compared to wt females of the same
Figure 4. Quantification of relative allelic transcription at EFNB1 (A) and XIST (B) by Pyrosequencing. In each figure, the part of the cDNA
sequence analysed is shown at the top, with the amplification primer sequences in bold, sequencing primers in lower case, and the polymorphic
base(s) enclosed by square brackets. Below, the dispensation order and allele-specific bases for comparison are indicated, with a table listing
the allele-specific incorporation of bases at each dispensation (denoted by subscripted numbers). The lower part shows pyrograms obtained
using genomic DNA from hemizygous males carrying each of the alleles under investigation, genomic DNA from subject I-2, genomic DNA from
a normal female and cDNA generated from peripheral blood from subject I-2. The allele-specific peaks used for quantification are marked with
arrows and raw measurements of comparative ratios indicated as percentages.
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Lox/15
4.870.1mm, n55). To observe whether cell sorting is disturbed
in female embryos heterozygous for the conditional allele, we
crossed Efnb1
Lox/1 females with males carrying both a GFP
transgene on the X chromosome (XEGFP) and an EphB2LacZ
allele, and examined embryos at E12.5. Examination of the limbs
of wt embryos under ultraviolet light showed random sorting of
cells positive and negative for GFP (Fig. 5B). By contrast, the limbs
of female Efnb1
Lox/1 heterozygous embryos showed clustering of
GFP-positive cells (expressing wt Efnb1) and GFP-negative cells
(expressing the conditional Efnb1 allele) as previously demon-
strated (Fig. 5D) [Compagni et al., 2003]. To determine whether
the abnormal cell mixing is of functional consequence, we stained
the embryos with b-galactosidase to determine expression of
EphB2, a receptor for ephrin-B1. There was normal EphB2
expression in the distal limb of wt mice (Fig. 5C), but patchy
expression in the limbs of mutants (Fig. 5E). Expression of EphB2
appeared increased in the areas where the conditional allele of
Efnb1 was expressed (negative for GFP) and decreased where the
wt Efnb1 transcript was active.
To investigate if the altered cell-sorting is also present in the
developing skull vault and neural tissue, transverse sections were
taken just above the level of the eye (Fig. 5F and G). Tissue in wt
embryos appeared to contain randomly mixed GFP-positive and
-negative cells (Fig. 5F and H), whereas in the Efnb1
Lox/1 mutant,
clusters of cells were visible (Fig. 5G and I) indicating a coarser
pattern of X inactivation likely related to homophilic cell sorting.
Discussion
This work was originally prompted by the molecular genetic
investigation of a girl with severe hypertelorism giving an
appearance resembling CFNS. Unexpectedly, she was found to
have a duplication of the EFNB1 gene, which was shown to
segregate with hypertelorism also present in the mother and
maternal grandmother, in the latter of whom we deduced that the
duplication is likely to have arisen de novo. The duplication
occurred in the proximity of repeat sequences (L1 LINE and
L1MDa repetitive elements) with a six-nucleotide homology at the
breakpoint, which most likely indicates a nonhomologous end
joining mechanism [Gu et al., 2008]. Because the phenotype in the
family overlaps with Teebi hypertelorism, we propose that testing
for dosage abnormalities in EFNB1 would be appropriate in
individuals presenting with this diagnosis in cases where X-linkage
cannot be excluded.
In addition to EFNB1, the duplication interval included two
other entirely duplicated genes, PJA1 encoding the RING-finger
protein Praja1 and STARD8, which encodes a cell junction
protein. Praja1 has been shown to interact with ubiquitin
conjugating enzymes and has independent ubiquitin ligase activity
[Yu et al., 2002]. In mice Pja1 is expressed in the developing limbs,
facial primordial, and central nervous system at E10.5, and has
been suggested to regulate the transcriptional function of the
developmentally important homeodomain protein Dlx5 [Gray
et al., 2004; Sasaki et al., 2002]. In the mouse Stard8 is widely
expressed; however, neither STARD8 nor PJA1 has been implicated
in congenital malformations in humans or mice. Our functional
studies both of the family and of the conditional mouse (discussed
below) support a major contribution of mis-regulated ephrin-B1
expression to the phenotype, but we cannot formally exclude a
contribution from duplication of either PJA1 or STARD8 in the
mechanism of the abnormalities seen in the family reported here.
We have shown that the duplicated X chromosome produces
 1.6 times as much EFNB1 mRNA as the normal X chromosome.
To explore the functional consequences of this we studied female
mice heterozygous for a conditional Efnb1 allele containing a
knock-in of the human cDNA sequence. Expression studies in
hemizygous males showed that this conditional allele was
Figure 5. Analysis of Efnb1
Lox/1 mice. A: 3D Micro-CTscan of an adult Efnb1
Lox/1 C57BL6/J skull. B–E: E12.5 limb buds: B: GFP in wt; C: EphB2
expression (b-galactosidase staining) in wt. D: GFP in Efnb1
Lox/1; E, EphB2 expression in Efnb1
Lox/1. F,G: Transverse section through E12.5 heads
showing GFP in wt (F) and Efnb1
Lox/1 (G). H,I: higher magnification of areas in rectangles in F and G, respectively (white arrowhead shows
abnormal boundary). Abbreviations: LAM, lambdoid suture; COR, coronal suture; FNS, frontonasal suture; PFS, posterior frontal suture; AFS,
anterior frontal suture.
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adult brain, but showed less marked imbalance in embryonic
heads (Supp. Fig. S1). Variations in amino acid sequence between
murine and human ephrin-B1 (in 12 of 271 residues encoded by
the human cDNA) might also contribute to functional differences
between the wt and conditional alleles. We observed abnormal cell
sorting (reflected in the coarser pattern of X-inactivation and
regulation of the receptor protein EphB2) in both the limbs and
heads of heterozygous Efnb1
Lox/1 mutant mice, which exhibited
significant hypertelorism. Collectively, the findings suggest
that abnormal cell sorting per se gives rise to hypertelorism,
irrespective of whether this is caused by underactive or overactive
EFNB1 alleles.
Abnormal cell sorting is by definition a noncell-autonomous
mechanism; this raises a paradox because hypertelorism (albeit of
lesser severity) is also present in males hemizygous for EFNB1 loss
of function mutations. Our finding that relatively mild imbalance
in EFNB1 expression between X chromosomes leads to a more
severe phenotype than hemizygous loss of function of EFNB1,
highlights the predominant contribution of noncell autonomous
abnormal sorting to hypertelorism. This is supported by the recent
report of a male with abnormalities similar to CFNS, including a
very wide midface and pronounced hypertelorism, in whom
mosaicism for an additional ring X chromosome (composed of a
24-Mb fragment containing the regions Xp11.3 to Xq13.1,
including EFNB1) was present in 45% of amniocytes and blood
leukocytes [Baker et al., 2010]. It is likely that the mosaicism for
EFNB1 contributed significantly to the craniofacial abnormalities in
this child. By contrast a male fetus carrying duplication of EFNB1
alone exhibited diaphragmatic hernia with no craniofacial abnorm-
alities [Srisupundit et al., 2010]. This suggests that although lack or
imbalance of ephrin-B1 may lead to hypertelorism, a uniform
excess does not adversely affect craniofacial development.
Analysis of Xenopus embryos suggests a mechanism for the
homophilic cell sorting observed in the female conditional Efnb1
mutant mouse embryos studied here [Lee et al., 2008]. This work
found that overexpression, as well as morpholino-mediated blocking
of endogenous Efnb1 expression, disrupted both the structure and
function of tight junctions in the epithelia of early stage Xenopus
embryos. These findings indicate that the level of Efnb1 expression is
crucial for maintaining appropriate localization of tight junction-
associated proteins; therefore, different levels of ephrin-B1 from each
active X chromosome may result in differential cell adhesion between
the two cell-populations. Recently, ephrin-B1 expression was found
to be regulated posttranscriptionally by miR-124 [Arvanitis et al.,
2010], this complex regulatory modulation further emphasizes the
importance of ephrin-B1 levels.
As a result of random X-inactivation in females, cells expressing
different levels of ephrin-B1 segregate from one another resulting
in patches of homophilically sorted cells. We show that expression
of EphB2, an important receptor of ephrin-B1, is upregulated in
patches coinciding with transcription of the conditional Efnb1
allele, resulting in abnormal sites of ligand–receptor interaction.
Such boundaries may affect cellular communication as ephrin-
B1–EphB2 interaction has been suggested to inhibit gap junction
formation by downregulating connexin-43 [Davy et al., 2006].
Taken together, these results provide insight into why females
heterozygous for loss of function or altered expression of EFNB1
develop a significantly more severe phenotype than males
hemizygous for loss of function mutations.
The mechanisms by which loss of function of EFNB1 or
imbalance in EFNB1 expression lead to a consistent phenotype of
hypertelorism remain unclear. Normal spacing of the orbits
depends on the correct development of a number of components
of the cranium: enlargement of the neurocranium at the metopic
suture, early growth at the frontoethmoidal suture, anterioposter-
ior growth at the cranial base, and growth at the frontomaxillary
and internasal suture [Cohen et al., 1995]. The position of the eyes
changes dramatically during development, and insights into the
control of orbital spacing come from developmental studies in the
chick and mouse [Abzhanov et al., 2007; Brugmann et al., 2010;
Cordero et al., 2004]. This work suggests that excess expression of
Fgf8 or Shh in the head ectoderm results in broadening of the
frontonasal process, thereby leading to abnormally widely spaced
eyes. Expression of Efnb1 in embryonic mutant mice has been
shown to be consistent with a role in maintaining separation of
neural crest from mesodermally derived tissue in the developing
skull vault [Twigg et al., 2004]. Further work will be necessary to
assess the effect of altered ephrin-b1 expression on migrating
neural crest cells and thereby shed light on the mechanism
underlying craniofacial abnormalities in Efnb1 mutant mice.
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